{"id":"W3088465353","doi":"10.1016/j.annonc.2020.08.924","title":"665P Impact of enzalutamide on patient-reported fatigue in hormone-sensitive prostate cancer (HSPC) or castration-resistant prostate cancer (CRPC)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"Janssen Biotech; Genentech; Active Biotech; Astellas Pharma; Incyte; Gilead Sciences; Alere; Sanofi; Genomic Health; GlaxoSmithKline; Myriad Genetics; Bristol-Myers Squibb; AstraZeneca; Astellas Foundation for Research on Metabolic Disorders; Amgen; Pfizer; Ipsen; Constellation Pharmaceuticals; Clovis Oncology; Astellas Pharma US","keywords":"Medicine; Enzalutamide; Prostate cancer; Asymptomatic; Cancer; Placebo; Internal medicine; Disease; Oncology; Androgen receptor; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002840149,0.0001775901,0.0003826923,0.00008525653,0.0001008308,0.0002554932,0.0001234238,0.0001854703,0.003142813],"category_scores_gemma":[0.0009124086,0.00005615556,0.000589756,0.0001271393,0.00008209943,0.0002117161,0.0001281923,0.0004215701,0.0001997251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000218886,"about_ca_system_score_gemma":0.0002756092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002494247,"about_ca_topic_score_gemma":0.006802736,"domain_scores_codex":[0.9998873,0.00005038702,0.00001008754,0.00001054355,0.00001331036,0.00002816838],"domain_scores_gemma":[0.9997501,0.00008715202,0.00005263315,0.00001035723,0.00002010356,0.00007958601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4344673,0.006669596,0.1283572,0.0009565512,0.00515186,0.0005270751,0.0001419942,0.003678116,0.01751694,0.0001920084,0.004612674,0.3977286],"study_design_scores_gemma":[0.01400937,0.08635229,0.8865736,0.000147417,0.002706947,0.0004282137,0.0001523964,0.002566622,0.002650493,0.0001855663,0.004193116,0.00003404407],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930249,0.003178253,0.00005972368,0.000264038,0.00006802645,0.00002757115,0.000606777,0.00002272778,0.002747947],"genre_scores_gemma":[0.9980261,0.0005463606,0.00008124137,0.0001245142,0.00002024803,0.00000980493,0.0003669373,0.000003225894,0.0008216696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003142813,"threshold_uncertainty_score":0.01051372,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1844628064692168,"score_gpt":0.4633122914543206,"score_spread":0.2788494849851038,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}